- Home
- CMS vs DGX Comparison
CMS vs DGX Comparison
Compare CMS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMS
- DGX
- Stock Information
- Founded
- CMS 1987
- DGX 1967
- Country
- CMS United States
- DGX United States
- Employees
- CMS N/A
- DGX N/A
- Industry
- CMS Power Generation
- DGX Medical Specialities
- Sector
- CMS Utilities
- DGX Health Care
- Exchange
- CMS Nasdaq
- DGX Nasdaq
- Market Cap
- CMS 20.7B
- DGX 19.8B
- IPO Year
- CMS N/A
- DGX 1996
- Fundamental
- Price
- CMS $72.81
- DGX $168.62
- Analyst Decision
- CMS Buy
- DGX Buy
- Analyst Count
- CMS 13
- DGX 15
- Target Price
- CMS $76.75
- DGX $185.40
- AVG Volume (30 Days)
- CMS 2.0M
- DGX 1.3M
- Earning Date
- CMS 07-31-2025
- DGX 07-22-2025
- Dividend Yield
- CMS 2.98%
- DGX 1.90%
- EPS Growth
- CMS 3.06
- DGX 12.66
- EPS
- CMS 3.38
- DGX 8.35
- Revenue
- CMS $7,786,000,000.00
- DGX $10,522,000,000.00
- Revenue This Year
- CMS $7.39
- DGX $10.35
- Revenue Next Year
- CMS $4.19
- DGX $3.96
- P/E Ratio
- CMS $21.55
- DGX $20.18
- Revenue Growth
- CMS 5.87
- DGX 12.58
- 52 Week Low
- CMS $62.33
- DGX $140.71
- 52 Week High
- CMS $76.45
- DGX $182.38
- Technical
- Relative Strength Index (RSI)
- CMS 63.58
- DGX 44.12
- Support Level
- CMS $69.75
- DGX $168.32
- Resistance Level
- CMS $73.60
- DGX $180.89
- Average True Range (ATR)
- CMS 1.01
- DGX 4.52
- MACD
- CMS 0.32
- DGX 0.07
- Stochastic Oscillator
- CMS 84.10
- DGX 24.45
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.